CD38-SADA / Y-mAbs Therap  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CD38-SADA / Y-mAbs Therap
NCT05994157: Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Not yet recruiting
1
30
US
CD38-SADA:177Lu-DOTA Complex
Y-mAbs Therapeutics
Non-hodgkin Lymphoma
01/27
01/28

Download Options